Racivir

Racivir
Systematic (IUPAC) name
	4-Amino-5-fluoro-1-[(2S,5R)-2-(hydroxymethyl)-1,3-oxathiolan-5-yl]pyrimidin-2(1H)-one
Clinical data
Pregnancy cat.	?
Legal status	?
Routes	Investigational
Identifiers
CAS number	137530-41-7
ATC code	None
PubChem	CID 454858
NIAID ChemDB	005245
Chemical data
Formula	C8H10FN3O3S
Mol. mass	247.25 g/mol
SMILES	eMolecules & PubChem
	InChI InChI=1S/C8H10FN3O3S/c9-4-1-12(8(14)11-7(4)10)5-3-16-6(2-13)15-5/h1,5-6,13H,2-3H2,(H2,10,11,14)/t5-,6+/m1/s1; Key:XQSPYNMVSIKCOC-RITPCOANSA-N ;

Racivir is an experimental nucleoside reverse transcriptase inhibitor (NRTI), developed by Pharmasset for the treatment of HIV.^[1] It is the enantiomer of emtricitabine, meaning that the two compounds are mirror images of each other.

[edit] References

This antiinfective drug article is a stub. You can help Wikipedia by expanding it.